SEC Form 4 · accession 0001235802-15-000017
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Feb 3, 2015
Accepted (ET)
Feb 4, 2015 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Feb 3, 2015 | C | 300,000 | — | A | 300,000 | D | |
| Common StockF1,F2,F3 | Feb 3, 2015 | C | 621,547 | — | A | 921,547 | D | |
| Common StockF1,F4,F3 | Feb 3, 2015 | C | 250,876 | — | A | 1,172,423 | D | |
| Common StockF1,F2,F3 | Feb 3, 2015 | C | 688,508 | — | A | 1,860,931 | D | |
| Common StockF1,F2,F3 | Feb 3, 2015 | C | 942,859 | — | A | 2,803,790 | D | |
| Common StockF1,F3 | Feb 3, 2015 | P | 352,941 | $17.00 | A | 3,156,731 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred StockF1,F3,F2 | — | Feb 3, 2015 | C | 1,200,000 | D | — | — | Common Stock | 300,000 | 0 | D |
| Series B Convertible Preferred StockF1,F3,F2 | — | Feb 3, 2015 | C | 2,486,188 | D | — | — | Common Stock | 621,547 | 0 | D |
| Series C Convertible Preferred StockF1,F3,F4 | — | Feb 3, 2015 | C | 743,466 | D | — | — | Common Stock | 250,876 | 0 | D |
| Series D Convertible Preferred StockF1,F3,F2 | — | Feb 3, 2015 | C | 2,754,034 | D | — | — | Common Stock | 688,508 | 0 | D |
| Series E Convertible Preferred StockF1,F3,F2 | — | Feb 3, 2015 | C | 3,771,438 | D | — | — | Common Stock | 942,859 | 0 | D |
Explanation of responses
- F1Reflects a 1-for-4 reverse stock split effected as of January 12, 2015.
- F2Each outstanding share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series D Convertible Preferred Stock and Series E Convertible Preferred Stock automatically converted into 1/4 of a share of the Issuer's common stock, immediately prior to the closing of the Issuer's initial public offering, for no additional consideration (subject to payment of cash for any fractional shares, in accordance with the Issuer's certificate of incorporation). These shares had no expiration date.
- F3The securities are owned directly by Split Rock Partners, LP ("SRP"). Voting and investment power over the securities is delegated to Split Rock Partners Management, LLC ("SRPM"), the general partner of SRP. SRPM has delegated voting and investment decisions to Michael Gorman, James Simons and David Stassen (collectively, the "General Partner Designees"), who require a two-thirds vote to act. Each of the General Partner Designees disclaims beneficial ownership of the securities except to the extent of any pecuniary interest therein.
- F4Each outstanding share of Series C Convertible Preferred Stock automatically converted into 0.3374 of a share of the Issuer's common stock, immediately prior to the closing of the Issuer's initial public offering, for no additional consideration (subject to payment of cash for any fractional shares, in accordance with the Issuer's certificate of incorporation). These shares had no expiration date.